Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Malfitano, Christiane ^a   Barboza, Catarina Andrade ^b   Mostarda, Cristiano ^c,d   da Palma, Renata Kelly ^a   dos Santos, Camila Paixão ^a   Rodrigues, Bruno ^b   Freitas, Sarah Cristina Ferreira ^a   Belló Klein, Adriane ^a,e   Llesuy, Susana ^a,f   Irigoyen, Maria Cláudia ^d   De Angelis, Kátia ^a  

^a UNIVERSIDADE NOVE DE JULHO   (Brazil)

^b SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autonomic modulation; Diabetic hyperglycemia; Myocardial infarction; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DISEASE ASSOCIATION; ENZYME ACTIVITY; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART RATE VARIABILITY; HYPERGLYCEMIA; MALE; NEUROMODULATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT; SYMPATHETIC DYSFUNCTION; VAGUS TONE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HYPERGLYCEMIA; MALE; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STREPTOZOCIN;

EID: 84988599447     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0131-x     Document Type: Article

References (48)

1. Jermendy G: Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol 2003, 40(Suppl 2):S370-S374.
2. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980, 49:95-108.
3. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979, 2:20-26.
4. Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 1997, 34:113-120.
5. Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhöffer A, Styk L: Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia? Basic Res Cardiol 2001, 96:160-168.
6. Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, Lakkisto P, Mervaala E, Voipio-Pulkki LM, Laine M, Tikkanen I: Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia 2004, 47:325-330.
7. Malfitano C, Alba Loureiro TC, Rodrigues B, Sirvente R, Salemi VM, Rabechi NB, Lacchini S, Curi R, Irigoyen MC: Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death. Eur J Heart Fail 2010, 12:659-667.
8. Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhöffer A, Styk J: Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem 2000, 210:143-151.
9. Chu LM, Osipov RM, Robich MP, Feng J, Oyamada S, Bianchi C, Sellke FW: Is hyperglycemia bad for the heart during acute ischemia? J Thorac Cardiovasc Surg 2010, 140:1345-1352.
10. Przyklenk K, Maynard M, Greiner DL, Whittaker P: Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal 2011, 12(5):781-790.
11. Li H, Bian Y, Zhang N, Guo J, Wang C, Lau WB, Xiao C: Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats. Cardiovasc Diabetol 2013, 12(1):91.
12. Wang T, Mao X, Li H, Qiao S, Xu A, Wang J, Lei S, Liu Z, Ng KF, Wong GT, Vanhoutte PM, Irwin MG, Xia Z: N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Rad Biol Med 2013, 12:291-303.
13. Rodrigues B, Rosa KT, Medeiros A, Schaan BD, Brum PC, De Angelis K, Irigoyen MC: Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. Cardiovasc Diabetol 2011, 10:26.
14. Hill MF, Singal PK: Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996, 148:291-300.
15. Wiernsperger NF: Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 2003, 29:579-585.
16. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol 2010, 8(6):e1000412.
17. Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, Curi R, Brum PC, Lacchini S, Montano N, De Angelis K, Irigoyen MC: Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J 2011, 32:904-912.
18. Farah VM, De Angelis K, Joaquim LF, Candido GO, Bernardes N, Fazan R Jr, Schaan BD, Irigoyen MC: Autonomic modulation of arterial pressure and heart rate variability in hypertensive diabetic rats. Clinics (Sao Paulo) 2007, 62(4):477-482.
19. Cerutti C, Barres C, Paultre C: Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis. Am J Physiol 1994, 266(5 Pt 2):H1993-H2000.
20. Malliani A, Pagani M: Spectral analysis of cardiovascular variabilities in the assessment of sympathetic cardiac regulation in heart failure. Pharmacol Res 1991, 24(Suppl 1):43-53.
21. De Angelis K, Oliveira AR, Werner A, Bock P, Bello-Klein A, Irigoyen MC: Exercise training in aging: hemodynamis, metabolic, and oxidative stress evaluations. Hypertension 1997, 3:767-771.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
23. Marklund S, Oreland L, Perdahl E, Winblad B: Superoxide dismutase activity in brains from chronic alcoholics. Drug Alcohol Depend 1983, 12:209-215.
24. Aebi H: Catalase in vitro. Methods Enzymol 1984, 105:121-126.
25. Flohe L, Gunzler W: Assays of glutathione peroxidase. Methods Enzymol 1984, 105:114-121.
26. Del Maestro R: Oxidative enzymes in tissue homogenates. In CRC Handbook of Methods for Oxygen Radical Research. 1st edition. Edited by Greenwald RA. Boca Raton, Florida: CRC Press Inc; 1985:294-296.
27. McCord JM, Fridovich I: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969, 244(22):6049-6055.
28. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994, 233:357-363.
29. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
30. Akerboom T, Sies H: Assay of glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol 1981, 77:373-382.
31. Malfitano C, De Angelis K, Fernandes T, Wichi RB, Rosa K, Pazzine M, Mostarda C, Ronchi FA, Oliveira EM, Casarini DE, Irigoyen MC: Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions. J Cardiovasc Pharmacol 2012, 59(1):58-65.
32. Schaan BD, Maeda CY, Timm HB, Medeiros S, Moraes RS, Ferlin E, Fernandes TG, Ribeiro JP, Schmid H, Irigoyen MC: Time course of changes in heart rate and blood pressure variability in streptozotocin-induced diabetic rats treated with insulin. Braz J Med Biol Res 1997, 30(9):1081-1086.
33. De Angelis KL, Oliveira AR, Dall'Ago P, Peixoto LR, Gadonski G, Lacchini S, Fernandes TG, Irigoyen MC: Effects of exercise training on autonomic and myocardial dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res 2000, 33(6):635-641.
34. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
35. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl JMed 2008, 358:2560-2572.
36. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, VitekME, Henderson WG, Huang GD: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl JMed 2009, 360:129-139.
37. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR: ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000, 101(17):2090-2096.
38. King LM, Opie LH: Glucose and glycogen utilization in myocardial ischemia -changes in metabolism and consequences for the myocyte. Mol Cell Biochem 1998, 180(1-2):3-26.
39. Ravingerova T, Neckar J, Kolar F: Ischemic tolerance of rat heart in acute and chronic phases of experimental diabetes. Mol Cell Biochem 2003, 249:167-174.
40. Xu G, Takashi E, Kudo M, Ishiwata T, Naito Z: Contradictory effects of short-and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol 2004, 76(1):57-65.
41. Malfitano C, de Souza Junior AL, Irigoyen MC: Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors. World J Cardiol 2014, 6(6):449-454.
42. Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003, 26(6):1895-1901.
43. Rodrigues B, Mostarda CT, Jorge L, Barboza CA, Grans CF, De Angelis K, Irigoyen MC: Impact of myocardial infarction on cardiac autonomic function in diabetic rats. J Diabetes Complications 2013, 27(1):16-22.
44. Schenkel PC, Tavares AM, Fernandes RO, Diniz GP, Bertagnolli M, da Rosa Araujo AS, Barreto-Chaves ML, Ribeiro MF, Clausell N, Belló-Klein A: Redox-sensitive prosurvival and proapoptotic protein expression in the myocardial remodeling post-infarction in rats. Mol Cell Biochem 2010, 341(1-2):1-8.
45. De Angelis KL, Cestari IA, Barp J, Dall'Ago P, Fernandes TG, de Bittencourt PI, Belló-Klein A, Belló AA, Llesuy S, Irigoyen MC: Oxidative stress in the latissimus dorsi muscle of diabetic rats. Braz J Med Biol Res 2000, 33:1363-1368.
46. Rosa CM, Xavier NP, Henrique Campos D, Fernandes AA, Cezar MD, Martinez PF, Cicogna AC, Gimenes C, Gimenes R, Okoshi MP, Okoshi K: Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats. Cardiovasc Diabetol 2013, 12(1):152.
47. Ansley DM, Wang B: Oxidative stress and myocardial injury in the diabetic heart. J Pathol 2013, 229(2):232-241.
48. Liu ZW, Zhu HT, Chen KL, Dong X, Wei J, Qiu C, Xue JH: Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol 2013, 12(1):158.